title: [In vitro activities of clofazimine against different drug-resistant types of Mycobacterium tuberculosis].
abstract: OBJECTIVE
  To study the in vitro antituberculous activities of clofazimine (CLF) to different drug-resistant types of Mycobacterium tuberculosis.
  
  
  METHODS
  The minimal inhibitory concentration (MIC) of CLF and isoniazid (INH), rifampicin (RFP), ofloxacin (OFLX), amikacin (AK), and capreomycin (CPM) against sensitive, single-drug resistant (SDR), poly-drug resistant (PDR), multi-drug resistant (MDR), and extensive-drug resistant (XDR) Mycobacterium tuberculosis strains isolated clinically were determined by microplate assays.
  
  
  RESULTS
  The MICs of CLF for sensitive, SDR, PDR, MDR and XDR strains of clinically isolated Mycobacterium tuberculosis were 0.06 - 4.00 mg/L, 0.03 - 4.00 mg/L, 0.06 - 8.00 mg/L, 0.06 - 8.00 mg/L, 0.03 - 8.00 mg/L. For the sensitive group, the MIC of CLF (0.06 - 4.00 mg/L) was higher than that of INH (0.06 - 0.25 mg/L) and RFP (0.06 - 0.25 mg/L), while there was no significant difference among OFLX (0.06 - 2.00 mg/L), AK (0.06 - 4.00 mg/L), and CPM (0.50 - 4.00 mg/L). For the single-drug resistant group, there was no significant difference among CLF (0.03 - 4.00 mg/L), INH (0.06 - 0.25 mg/L), and RFP (0.06 - 0.25 mg/L), but the MIC of CLF was lower than that of OFLX (0.25 - 8.00 mg/L), AK (0.06 - 4.00 mg/L), and CPM (0.50 - 8.00 mg/L). For the MDR group, there was no significant difference between CLF (0.06 - 8.00 mg/L) and AK (0.25 - 8.00 mg/L), but the MIC of CLF was lower than that of OFLX (0.125 - 8.00 mg/L) and CPM (0.50 - 8.00 mg/L). For the XDR group, the MIC of CLF (0.03 - 8.00 mg/L) was lower than that of others.
  
  
  CONCLUSIONS
  CLF showed good in vitro activity against Mycobacterium tuberculosis, especially MDR and XDR strains.
authors.affiliation: Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, China.
authors.forename: Xu-wei
authors.initials: XW
authors.lastname: Gui
authors.forename: He-ping
authors.initials: HP
authors.lastname: Xiao
authors.forename: Zhong-yi
authors.initials: ZY
authors.lastname: Hu
authors.forename: Zhen-ling
authors.initials: ZL
authors.lastname: Cui
authors.forename: Jie
authors.initials: J
authors.lastname: Wang
authors.forename: Jun-mei
authors.initials: JM
authors.lastname: Lu
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology*; D002991:Clofazimine / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification
chemical_list: D000995:Antitubercular Agents; D002991:Clofazimine